Real‐world effects of long‐term rifaximin treatment for Japanese patients with hepatic encephalopathy-Reference-Cited by-同舟云学术

Real‐world effects of long‐term rifaximin treatment for Japanese patients with hepatic encephalopathy

Published:2019-08-09 Issue:12 Volume:49 Page:1406-1413
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Suzuki Hiroyuki¹,Sezaki Hitomi¹^ORCID,Suzuki Fumitaka¹,Kasuya Kayoko¹,Sano Tomoya¹^ORCID,Fujiyama Shunichiro¹^ORCID,Kawamura Yusuke¹^ORCID,Hosaka Tetsuya¹^ORCID,Akuta Norio¹^ORCID,Saitoh Satoshi¹,Kobayashi Masahiro¹,Arase Yasuji¹,Ikeda Kenji¹,Suzuki Yoshiyuki¹,Kumada Hiromitsu¹

Affiliation:

1. Department of HepatologyToranomon Hospital Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13415

Reference38 articles.

1. Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases

2. Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial

3. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis